KRMD250117C7500
- 0.00
- 0.000.00%
KORU Medical Systems Newsroom
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference
CCORF Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Maintains Target Price $4
Craig-Hallum Maintains Buy on KORU Medical Systems, Raises Price Target to $5
KORU Medical Systems Is Maintained at Overweight by Piper Sandler
KORU Medical Systems Analyst Ratings
CCORF Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Raises Target Price to $4
Piper Sandler Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Raises Target Price to $3.5
A Quick Look at Today's Ratings for KORU Medical Systems(KRMD.US), With a Forecast Between $3.5 to $4
Express News | KORU Medical Systems Inc : Piper Sandler Raises Target Price to $3.50 From $3
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript Summary
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $8.2M
Express News | KORU Medical Systems Inc: Reiterating Cash Flow Breakeven in Q4 of 2024 and Cash Flow Positive for Full Year 2025
KORU Medical Systems Non-GAAP EPS of -$0.03 Beats by $0.01, Revenue of $8.2M Beats by $0.49M
KORU Medical Systems | 10-Q: Q3 2024 Earnings Report
Express News | KORU Medical Systems Q3 Gross Margin 63%
Express News | KORU Medical Systems Outlook FY Revenue USD 32.75-33.25 Million
Press Release: KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance